Recommendations and Guidelines:
ACIP Live Meeting Archive - June 2011
ACIP pages:
June 22-23, 2011
Note: All Files are in 
(.zip) Format
June 22, 2011 (Day 1)
Welcome
- Opening Remarks
Dr. L Pickering
Herpes Zoster (HZ) Vaccine
- Introduction
Dr. P Cieslak - Update: Zoster Vaccine for Adults 50-59 Years of Age
Dr. R Harpaz
Meningococcal Vaccine (MCV)
- Meningococcal Vaccines Work Group Update
Dr. C Meissner - Menactra Infant Indication
Dr. D Johnson - Recommendations for Use of MCV4-D among Children
Dr. A Cohn - VFC Resolution Update: MCV
Dr. L Rodewald - Introduction of MenAfriVac into Sub-Saharan Africa
Dr. T Clark
MMR Vaccine Work Group Update
- Introduction
Dr. J Temte - Measles Update – United States, January – June 17, 2011
Dr. H McLean
Pertussis Vaccine
- Introduction
Dr. M Sawyer
Safety of Maternal Tdap Vaccination for Mother and Fetus
Dr. S Rasmussen - Tdap Vaccination to Prevent Pertussis in Infants
Dr. G Asay - Pertussis Maternal Immunization Study Update
Dr. J Liang - Does “cocooning” work to prevent pertussis in infants?
Dr. J Liang - Timing of Maternal Tdap Vaccination: during pregnancy or postpartum?
Dr. J Liang
Vaccine Supply
- Update
Dr. L Rodewald
Human Papillomavirus (HPV) Vaccines
- Introduction
Dr. J Englund - Background
Dr. L Markowitz - Quadrivalent HPV Vaccine
Dr. A Saah - HPV-associated Oropharyngeal Cancer
Dr. A Kreimer - HPV Vaccine Cost-effectiveness, Updates and Review
Dr. H Chesson - Policy Considerations: HPV Vaccine for Males
Dr. E Dunn
June 23, 2011 (Day2)s
General Recommendations: Febrile Seizures
- Introduction
Dr. J Duchin - Clinical Febrile Seizures
Dr. H Keyserling - Febrile Seizures After Trivalent Inactivated Influenza Vaccine: Update
Dr. J Tokars - Burden of Disease - Information for Providers
Dr. A Kroger
Hepatitis B Vaccine (HBV)
- Introduction
Dr. M Sawyer - Acute Hepatitis B Incidence Among Adults With and Without Diabetes
Ms. M Reilly - Cost-Effectiveness Analysis of Hepatitis B Vaccination among Adults with Diabetes
Dr. T Hoerger - Hepatitis B Vaccination for Adults with Diabetes - Proposed Recommendations
Dr. T Murphy
13-valent Pneumococcal Conjugate Vaccine (PCV13)
- Introduction
Dr. M Marcy - Pneumococcal Disease Prevention Among Adults
T Pilishvili
Influenza
- Introduction
Dr. W Keitel - Proposed Vaccination 2011-2012
Dr. L Grohskopf - Adverse Events following Fluzone® High-Dose
Dr. P Moro - Fluzone® High-Dose Vaccine: One Year Post-Approval
Dr. D Johnson - Fluzone Intradermal®: A New Option for Influenza Prevention
Dr. D Johnson
* For assistance with zipped files, please consult the "downloading" page.
This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.
File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)
This page last modified on May 14, 2012
Content last reviewed on March 21, 2011
Content Source: National Center for Immunization and Respiratory Diseases
